Lee, A.M.; Ferdjallah, A.; Moore, E.; Kim, D.C.; Nath, A.; Greengard, E.; Huang, R.S.
Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma. Int. J. Mol. Sci. 2021, 22, 11168.
https://doi.org/10.3390/ijms222011168
AMA Style
Lee AM, Ferdjallah A, Moore E, Kim DC, Nath A, Greengard E, Huang RS.
Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma. International Journal of Molecular Sciences. 2021; 22(20):11168.
https://doi.org/10.3390/ijms222011168
Chicago/Turabian Style
Lee, Adam M., Asmaa Ferdjallah, Elise Moore, Daniel C. Kim, Aritro Nath, Emily Greengard, and R. Stephanie Huang.
2021. "Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma" International Journal of Molecular Sciences 22, no. 20: 11168.
https://doi.org/10.3390/ijms222011168
APA Style
Lee, A. M., Ferdjallah, A., Moore, E., Kim, D. C., Nath, A., Greengard, E., & Huang, R. S.
(2021). Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma. International Journal of Molecular Sciences, 22(20), 11168.
https://doi.org/10.3390/ijms222011168